마드리갈 파마슈티컬스, Inc.
US ˙ NasdaqGS ˙ US5588681057

SecurityMDGL / Madrigal Pharmaceuticals, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in MDGL / Madrigal Pharmaceuticals, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Madrigal Pharmaceuticals, Inc. (US:MDGL) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 13,493 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -13,493 -100.00 0 -100.00
2025-11-13 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 13,493 -6,150 -31.31 6,189 4.10 0.0072
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 19,643 4,643 30.95 5,945 19.67 0.0073
2025-08-14 2025-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 15,000 0 0.00 4,968 7.32 0.0062
2025-05-15 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 15,000 0 4,968 0.0041
2025-02-14 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 15,000 0 0.00 4,629 45.43 0.0056
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 15,000 -13,500 -47.37 3,183 -60.14 0.0034
2024-08-09 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 -30,457 -51.66 7,985 -49.28 0.0092
2024-05-14 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 58,957 30,457 106.87 15,744 138.76 0.0179
2024-02-14 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 0.00 6,594 58.43 0.0076
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 0.00 4,162 -36.79 0.0052
2023-10-27 2023-06-30 13F/A-2 MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 0.00 6,584 -4.63 0.0075
2023-10-12 2023-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 6,584 0.0066
2023-08-14 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 6,584 0.0067
2023-06-01 2023-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 0.00 6,904 -16.54 0.0082
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 6,904 0.0063
2023-02-21 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 -849 -2.89 8,272 331.51 0.0098
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 29,349 -145 -0.49 1,917 -9.19 0.0024
2022-08-17 2022-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 29,494 0 0.00 2,111 -27.06 0.0024
2022-08-15 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 29,494 0 2,111 0.0008
2022-05-16 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 29,494 0 0.00 2,894 15.81 0.0022
2022-02-11 2021-12-31 13F Synta Pharmaceuticals COM 558868105 29,494 0 0.00 2,499 6.20 0.0021
2021-11-12 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 29,494 743 2.58 2,353 -15.96 0.0020
2021-08-13 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,751 0 0.00 2,800 -16.74 0.0023
2021-05-14 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,751 -69 -0.24 3,363 4.96 0.0048
2021-02-16 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,820 0 0.00 3,204 -6.37 0.0047
2020-11-13 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,820 0 0.00 3,422 4.84 0.0058
2020-08-11 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,820 320 1.12 3,264 71.52 0.0056
2020-05-15 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 0.00 1,903 -26.72 0.0039
2020-03-18 2019-12-31 13F/A-2 MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 0.00 2,597 5.70 0.0037
2020-02-28 2019-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 2,597 0.0038
2020-02-14 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 2,597 3,259.0149
2019-11-14 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 0.00 2,457 -17.74 0.0041
2019-11-06 2019-06-30 13F/A-2 MADRIGAL PHARMACEUTICALS COM 558868105 28,500 -12,100 -29.80 2,987 -41.27 0.0050
2019-09-24 2019-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 28,500 0 2,987 0.0051
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,500 -12,100 2,987
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 40,600 1,500 3.84 5,086 15.41 0.0087
2019-02-15 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 39,100 6,400 19.57 4,407 -37.06 0.0085
2018-11-15 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 32,700 8,900 37.39 7,002 5.18 0.0114
2019-03-21 2018-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 23,800 23,800 6,657 0.0115
2018-08-14 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 23,800 6,657 0.0115
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.